Ecto-5'-nucleotidase expression is associated with the progression of renal cell carcinoma.
about
Ecto-5'-nucleotidase (CD73) is a biomarker for clear cell renal carcinoma stem-like cells.Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacyPrognositic value of CD73-adenosinergic pathway in solid tumor: A meta-analysis and systematic review.Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers.
P2860
Ecto-5'-nucleotidase expression is associated with the progression of renal cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Ecto-5'-nucleotidase expressio ...... ssion of renal cell carcinoma.
@ast
Ecto-5'-nucleotidase expressio ...... ssion of renal cell carcinoma.
@en
type
label
Ecto-5'-nucleotidase expressio ...... ssion of renal cell carcinoma.
@ast
Ecto-5'-nucleotidase expressio ...... ssion of renal cell carcinoma.
@en
prefLabel
Ecto-5'-nucleotidase expressio ...... ssion of renal cell carcinoma.
@ast
Ecto-5'-nucleotidase expressio ...... ssion of renal cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Ecto-5'-nucleotidase expressio ...... ssion of renal cell carcinoma.
@en
P2093
Guangming Zhou
Hailong Pei
Zhongjin Yue
P2860
P304
P356
10.3892/OL.2015.3138
P577
2015-04-23T00:00:00Z